2016 BINDER Innovation Prize: Research into Egg Cell Defects
Dr. Melina Schuh has been awarded the BINDER Innovation Prize for her research into the development of fertile egg cells in mammals
Dr. Melina Schuh has been awarded the BINDER Innovation Prize for her research into the development of fertile egg cells in mammals
The epoc® Blood Analysis System provides the fast and accurate results that clinicians need to make accelerated treatment decisions
Exhibitor highlights from ESCMID’s annual congress in Amsterdam
Life science companies combine expertise to enhance transcriptome research
Findings from Sheffield Teaching Hospitals NHS Trust
ImageXpress and MetaXpress High-Content Toolset enables breakthrough Three-Dimensional assay development and Screening Workflow for cellular research
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
iPLEX® HS chemistry enables multiplex detection down to 1% allele frequency
New platform enables researchers to rapidly identify cutting-edge anti-cancer drugs
Researchers’ use of ParsortixTM System for studies into multiple cancers confirms the cell separation technology’s ability to harvest viable circulating tumor cells for a broad range of downstream analyses
Products reviewed by clinical scientists around the world
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
Leica Microsystems launches sCMOS microscope camera
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
DxN VERIS Molecular Diagnostics System Showcasing on Booth #52 and at Symposium
Digital flow morphology delivers workflow improvements, reducing the need for manual microscope review
In vitro diagnostic approved to support use of Bristol-Myers Squibb’s OPDIVO® for non-squamous non-small cell lung cancer